Matsunaga K, Mashiba H, Kurano A, Jimi S
Division of Immunology, National Kyushu Cancer Center, Fukuoka, Japan.
J Clin Immunol. 1990 Sep;10(5):265-72. doi: 10.1007/BF00916702.
The cytotoxin production by regional lymph node cells was examined in 25 patients with uterine cervical cancer and 10 patients with uterine myoma. The patients in stage I had significantly increased spontaneous release of cytotoxins compared with that in stages II, III, and IV. The spontaneous release in stages III and IV was markedly reduced. There was no difference in the release of cytotoxins from peripheral blood lymphocytes between cancer patients and patients with myoma or healthy controls. The cytotoxin production by lymph node cells was increased in stage III by stimulating with formalin-fixed QG-K cells derived from uterine cervical cancer, but not in stages I and II. Almost all of the cytotoxic activity of cytotoxin was abrogated by antilymphotoxin antibody. However, the cytotoxin activity was partially inhibited by anti-tumor necrosis factor antibody. These results suggest that cytotoxins released from the regional lymph node cells of uterine cancer patients are derived from, most of all, lymphotoxin.
对25例子宫颈癌患者和10例子宫肌瘤患者的区域淋巴结细胞产生细胞毒素的情况进行了检测。I期患者的细胞毒素自发释放量与II期、III期和IV期相比显著增加。III期和IV期的自发释放量明显降低。癌症患者与子宫肌瘤患者或健康对照者外周血淋巴细胞的细胞毒素释放没有差异。通过用源自子宫颈癌的福尔马林固定的QG-K细胞刺激,III期淋巴结细胞的细胞毒素产生增加,但I期和II期没有增加。几乎所有细胞毒素的细胞毒性活性都被抗淋巴细胞毒素抗体消除。然而,细胞毒素活性被抗肿瘤坏死因子抗体部分抑制。这些结果表明,子宫癌患者区域淋巴结细胞释放的细胞毒素主要来源于淋巴细胞毒素。